Effect of low dose acetylsalicylic acid and anticoagulant on clinical outcomes in COVID‐19, analytical cross‐sectional study

BACKGROUND AND AIMS: The therapeutic strategy for the treatment of known sequelae of COVID‐19 has shifted from reactive to preventative. In this study, we aim to evaluate the effects of acetylsalicylic acid (ASA), and anticoagulants on COVID‐19 related morbidity and mortality. METHODS: This record‐b...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Muhammad B., Amer, Samar A., Merrell, Eric, Russo, Ronald, Riley, Jeffrey B., Scro, Austin, James, Elizabeth, Anuforo, Anderson, Adhikari, Soumya, Siciliano, Rosalie, Chebaya, Philip, Darling, Edward, Kuhn, Michael, Nieman, Gary, Shawkat, Ahmed, Aiash, Hani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273938/
https://www.ncbi.nlm.nih.gov/pubmed/35844823
http://dx.doi.org/10.1002/hsr2.699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273938/
https://www.ncbi.nlm.nih.gov/pubmed/35844823
http://dx.doi.org/10.1002/hsr2.699

Ejemplares similares